Showing results (261-270 of 300) with videos related to

Sort By:
Pageof 30
Leukemia|December 19, 2015
CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic valueA Pardanani, K K Reichard, D Zblewski, et al.
British Journal of Haematology|February 15, 2002
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemiaD F Jelinek, R C Tschumper, S M Geyer, et al.
Leukemia|March 6, 2009
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlatesA Tefferi, R L Levine, K-H Lim, et al.
Leukemia|March 26, 2004
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myelomaL F Porrata, M A Gertz, S M Geyer, et al.
Mayo Clinic Proceedings|November 1, 1989
Acute megakaryocytic leukemia (M7) in childrenK P Windebank, A Tefferi, W A Smithson, et al.
Leukemia|June 2, 2007
TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutationsA Pardanani, J Hood, T Lasho, et al.
Bone Marrow Transplantation|June 29, 2010
Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCTH Hebart, C Lengerke, P Ljungman, et al.
Leukemia|October 7, 2006
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myelomaR Fonseca, S A Van Wier, W J Chng, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 10, 2015
Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patientsD J Wojenski, G T Bartoo, J A Merten, et al.
British Journal of Haematology|July 27, 2001
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasiaR A Mesa, A Tefferi, M A Elliott, et al.
Pageof 30